MARKET

INO

INO

Inovio Pharmaceu
NASDAQ
1.210
0.000
0.00%
After Hours: 1.220 +0.01 +0.83% 19:50 07/08 EDT
OPEN
1.200
PREV CLOSE
1.210
HIGH
1.240
LOW
1.171
VOLUME
1.56M
TURNOVER
--
52 WEEK HIGH
2.979
52 WEEK LOW
1.030
MARKET CAP
99.55M
P/E (TTM)
-0.7110
1D
5D
1M
3M
1Y
5Y
1D
Inovio Pharmaceuticals Inc. Stock Falls 4.9%, Underperforms Peers
Dow Jones · 2d ago
Weekly Report: what happened at INO last week (0629-0703)?
Weekly Report · 3d ago
Inovio Pharmaceuticals May Offer Up To $300 Mln Of Securities
Benzinga · 6d ago
INOVIO PHARMACEUTICALS - MAY OFFER UP TO $300 MLN OF SECURITIES - SEC FILING
Reuters · 6d ago
WHO Director-General Ghebreyesus Says He Considers The Cruise Ship-Linked Hantavirus Outbreak To Be Over
Benzinga · 6d ago
Inovio Pharmaceuticals Inc. Stock Advances 8.2%, Outperforms Peers
Dow Jones · 07/01 20:34
Weekly Report: what happened at INO last week (0622-0626)?
Weekly Report · 06/29 09:46
CDC Raises Its Response Level To Congo Ebola Outbreak To Level 1 Activation, Its Highest Level; Says Risk Of Ebola Spreading In The U.S. Remains Low
Benzinga · 06/26 17:10
More
About INO
Inovio Pharmaceuticals, Inc. is a biotechnology company focused on developing and commercializing deoxyribonucleic acid (DNA) medicines to help treat and protect people from human papillomavirus (HPV)-related diseases, cancer, and infectious diseases. Its proprietary investigational CELLECTRA devices are designed to deliver the plasmids into the body’s cells for optimal effect, without the use of chemical adjuvants, lipid nanoparticles or viral vectors. Its lead candidate is INO-3107 for the treatment of recurrent respiratory papillomatosis (RRP), a chronic, rare and debilitating disease caused by HPV-6 and HPV-11. Its DNA medicines in the pipeline include INO-3112 for the Treatment of HPV-related Oropharyngeal Squamous Cell Carcinoma, VGX-3100 for the Treatment of HPV-related Cervical HSIL, VGX-3100 for the Treatment of Anal or Perianal HSIL, INO-5401 for the Treatment of Glioblastoma Multiforme (GBM), and INO-5401 for the Prevention of Cancer for People with BRCA1/2 Mutation.

Webull offers Inovio Pharmaceuticals Inc stock information, including NASDAQ: INO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, INO stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading INO stock methods without spending real money on the virtual paper trading platform.